Florida Governor Signs Bill to Establish Registry of Banned Vape Products

Regulations by 2FIRSTS.ai

Apr.28.2024

Florida Governor Signs Bill to Establish Registry of Banned Vape Products

Florida Governor Ron DeSantis signed 28 bills last Friday, including one regulating e-cigarette products, targeting disposable e-cigarettes.

According to CBS News on April 26, Governor Ron DeSantis of Florida signed 28 bills last Friday, including one related to regulating the management of e-cigarette products.

On Friday, Governor DeSantis signed a bill (HB 1007) targeting e-cigarette products for children, crafted by Attorney General Ashley Moody. The legislation primarily focuses on disposable e-cigarettes and allows Moody's office to establish a registry of banned products after an administrative process.

References:

[1] DeSantis signs AI and vape bills

Also Read:

[1] Undercover Police Operation Targets Illegal Nicotine E-cigarette Sales in Florida

[2] Florida Legislature Takes Action to Regulate E-Cigarettes Market

[3] Florida Supreme Court Approves Recreational Marijuana Legalization Vote

[4] Florida State Passes Law Targeting Children's E-Cigarette Products

[5] Florida Vape Shops Facing Crisis amid Restrictions

[6] Juul Supports Legislation to Regulate Nicotine Products in Florida

[7] Florida Environmental Committee Supports Measures to Regulate Smoking in State Parks

#North America #United States #Disposable e-cigarettes #Regulation #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Organigram Global Appoints James Yamanaka, Former Global Head of Strategy at British American Tobacco, as CEO

James Yamanaka, former Global Head of Strategy at British American Tobacco, appointed CEO of Organigram Global.

Nov.26 by 2FIRSTS.ai

BAT accused of “utter hypocrisy” over efforts to dilute Zambia’s tobacco bill

The Guardian reports that British American Tobacco urged Zambian ministers to drop or delay ad and sponsorship bans and to soften a draft tobacco bill by shrinking health warnings, easing flavour restrictions and lowering penalties. Critics said the stance is hypocritical given similar rules apply in the UK.

Nov.13

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Company | Bloomberg: JTI Bets on Value Cigarettes Against the Tide, While Steadily Expanding Heated Tobacco Globally

Bloomberg reports that Japan Tobacco International (JTI) is pursuing a strategy that contrasts with peers such as Philip Morris International (PMI) and British American Tobacco (BAT). While global tobacco majors push “smoke-free” transitions, JTI continues to cultivate combustible cigarettes—particularly value brands in the United States—while advancing the global rollout of its heated-tobacco brand Ploom. JTI forecasts that value-priced cigarettes will exceed a 40% share of the U.S. market by 2